NorthRock Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Buy |
874
+166
| +23% | +$87.2K | 0.01% | 422 |
|
|
2025
Q1 | $449K | Sell |
708
-94
| -12% | -$59.6K | 0.02% | 367 |
|
|
2024
Q4 | $571K | Sell |
802
-156
| -16% | -$111K | 0.02% | 320 |
|
|
2024
Q3 | $1.01M | Buy |
958
+235
| +33% | +$247K | 0.03% | 209 |
|
|
2024
Q2 | $760K | Buy |
723
+64
| +10% | +$67.3K | 0.03% | 236 |
|
|
2024
Q1 | $634K | Buy |
659
+20
| +3% | +$19.3K | 0.02% | 297 |
|
|
2023
Q4 | $561K | Buy |
639
+390
| +157% | +$343K | 0.02% | 291 |
|
|
2023
Q3 | $205K | Buy |
+249
| New | +$205K | 0.02% | 333 |
|
|
2023
Q2 | – | Sell |
-349
| Closed | -$287K | – | 338 |
|
|
2023
Q1 | $287K | Sell |
349
-17
| -5% | -$14K | 0.03% | 228 |
|
|
2022
Q4 | $264K | Buy |
+366
| New | +$264K | 0.03% | 271 |
|
|
2021
Q4 | – | Sell |
-589
| Closed | -$356K | – | 352 |
|
|
2021
Q3 | $356K | Buy |
+589
| New | +$356K | 0.03% | 193 |
|